Home > Insider Trading > Filing (0001209191-13-045538)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1455271	Griffin-American Healthcare Reit Ii Inc.	NONE	Real Estate Investment Trusts (6798)	264008719

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1504537	B. Mathieu Streiff	C/O Griffin-American Healthcare Reit Ii, Inc., 18191 Von Karman Ave., Suite 300 Irvine CA 92612	Evp, General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-09-20	284	$9.20	58,398	No	4	P	Indirect	Streiff Family Trust, UA DTD 3/26/2013
Common Stock	Acquisiton	2013-09-20	14,029	$9.20	77,105	No	4	J	Indirect	By American Healthcare Investors LLC
Common Stock	Acquisiton	2013-09-23	48,924	$9.20	107,322	No	4	P	Indirect	Streiff Family Trust, UA DTD 3/26/2013

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Streiff Family Trust, UA DTD 3/26/2013
No	4	J	Indirect	By American Healthcare Investors LLC
No	4	P	Indirect	Streiff Family Trust, UA DTD 3/26/2013

Footnotes

The reported shares of common stock were acquired at $9.198 per share by Mr. Streiff pursuant to an Executive Stock Purchase Plan between Mr. Streiff and the Issuer, entered into effective 1/1/2013.
The reported shares of common stock are held directly by Streiff Family Trust, UA DTD 3/26/2013, and indirectly by Mathieu Streiff, Trustee.
The shares were issued pursuant to a Sub-advisory Agreement, dated November 7, 2011, whereby American Healthcare Investors LLC provides services to the Issuer and recieves shares of the Issuer's common stock, in lieu of certain cash compensation.
The reported shares of common stock are owned directly by American Healthcare Investors LLC, a limited liability company of which Mr. Streiff is a principal. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for the purposes of Section 16 or for any other purpose.
The reported shares of common stock were acquired through the Issuer's follow-on public offering at $9.198 per share, reflecting the elimination of selling commissions and the dealer manager fee in connection with such transaction